Key result
Lidocaine facilitates inducible ventricular tachyarrhythmias in ~88% of dogs with chronic ischemic damage.
Why the study?
The arrhythmogenic effects of lidocaine in the presence of chronic myocardial ischemic injury were not well characterized.
Does lidocaine induce ventricular arrhythmias in a canine model of chronic myocardial ischemic damage?
Does lidocaine induce ventricular arrhythmias in a canine model of chronic myocardial ischemic damage?
In a canine model of ischemic injury, lidocaine demonstrated arrhythmogenic properties by facilitating the induction of ventricular tachyarrhythmias and prolonging delayed electrical activity.
Answers are grounded in this paper and cite their sources.
May caution lidocaine use in chronic ischemia; leaves open translation to human arrhythmia risk.
Lidocaine facilitated the induction of ventricular arrhythmias by programmed electrical stimulation in 16 dogs, 5 to 14 days after a temporary (90-min) occlusion of the left anterior descending coronary artery. In these 16 animals, programmed stimulation failed to produce ventricular tachyarrhythmias in any animal before lidocaine administration (3 mg/kg), while after lidocaine administration, programmed stimulation produced nonsustained ventricular tachycardia in four animals (25%), sustained ventricular tachycardia in nine animals (56%), and ventricular fibrillation in one animal (6%). Delayed electrical activity in ischemically injured ventricular myocardium produced by premature ventricular stimuli (mean +/- SD = 179 +/- 34 ms) was delayed further by the administration of lidocaine (237 +/- 42 ms, p less than 0.01), resulting in continuous local electrical activity between the final premature ventricular stimulus and the initial beat of the resultant ventricular tachycardia. Lidocaine administration did not alter myocardial refractoriness in normal ventricular tissue, but it prolonged refractoriness in ischemically injured ventricular myocardium. These results show that lidocaine can have arrhythmogenic actions when administered in the presence of existing ischemic injury, possibly the result of increased delay in activation of ischemically injured ventricular myocardium with localized reentry of myocardial electrical activity.
No takes yet. Share an insight, caveat, or question.
Patterson et al. (1982) studied Chronic Myocardial Ischemic Damage (n=16). Lidocaine vs. Baseline (before lidocaine administration) was evaluated on Induction of ventricular tachyarrhythmias by programmed electrical stimulation. Lidocaine administration facilitated the induction of ventricular tachyarrhythmias in 87.5% of dogs with chronic myocardial ischemic damage, compared to 0% before administration.
Synapse has enriched 10 related papers. Consider them for comparative context: